POWA 2.0
Food supplement declared in France, declaration No 2019-11-390
POWA 2.0 (PROZIS) is a food supplement declared in France. Status: retiré du marché le 9 March 2024. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- PROZIS
- Food business operator placing the product on the market
- Prozis.Com, S.A.
- Status
- Retiré du marché le 9 March 2024
- Form
- Poudre
- Daily dose
- 15 g
- Directions for use
- Prendre 1dose 30-45 min. avant l'entraînement.Pour préparer 1dose, ajouter 15g (2 doseurs à ras ou..
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous anticoagulants, Sous antidépresseurs, Sous antidiabétiques, Sous traitement médicamenteux
- Objectives stated by the manufacturer (these are not authorised claims)
- Sport
- Flavourings
- Pomme Verte
Declaration 166232, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 9 March 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Paullinia cupana Kunth | Graine | Extrait sec hydroalcoolique | 150 mg |
| Panax ginseng C.A.Mey. | Racine | Extrait sec hydroalcoolique | 75 mg |
| Pinus massoniana Lamb. | Ecorce | Extrait sec hydroalcoolique | 15 mg |
| Salvia miltiorrhiza Bunge | Racine | Extrait sec hydroalcoolique | 7.5 mg |
| Ginkgo biloba L. | Feuille | Extrait sec hydroalcoolique | 4.5 mg |
| Ophiopogon japonicus (Thunb.) Ker Gawl. | Racine | Extrait sec hydroalcoolique | 3.8 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Créatine monohydrate | not declared |
| L-citrulline malate | not declared |
| Bêta-alanine | not declared |
| L-Arginine-alpha-cétoglutarate | not declared |
| Taurine | not declared |
| Caféine | not declared |
| Quercétine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
Additives
E330, E341, E955, E950, E555, E171
Other ingredients
maltodextrine, Concentré de spiruline et carthame
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Contient de la caféine (183 mg/dose journalière). Déconseillé aux enfants et aux femmes enceintes. Déconseillé aux femmes allaitantes. Ce produit n'est pas recommandé aux personnes sous antidépresseurs. En raison de la présence de créatine, ce produit est réservé aux adultes uniquement. Consulter un médecin en cas de prise de médicaments, y compris des anticoagulants, des antiplaquettaires ou des antidiabétiques. Certaines personnes peuvent ressentir des picotements dus à la teneur en bêta-alanine. Ne pas dépasser la dose journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la portée des enfants. Conserver dans l'emballage d'origine dans un endroit frais et sec, à l'abri du soleil.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Powa 2.0 Prozis, declared in 2023, withdrawn from the market : different composition: 2 ingredient(s) added, 2 missing
- POWA 2.0 PROZIS, declared in 2023, withdrawn from the market : different composition: 1 ingredient(s) added, 2 missing
- Powa 2.0 Prozis, declared in 2022, withdrawn from the market : different composition: 2 ingredient(s) added, 2 missing
Brand : PROZIS